Cologne, Germany

University Hospital Cologne

University Hospital Cologne employs more than 1000 doctors with the highest category and more than 10 000 employees, who annually improve their qualifications at the bases of clinical institutions in the USA, Great Britain, and France. On the basis of the University Hospital, new methods of treating many diseases are being developed.

Send treatment request

The clinic representatives will contact you to answer all your questions and help you book an appointment.

I agree to the Privacy Policy and Terms and Conditions

About Univesity Hospital Cologne

University Hospital Cologne consists of highly specialized centers and hospitals. It annually receives more than 200 000 patients from all over the world. Doctors improve the already known methods of diagnostics and treatment, as well as develop innovative ways to deal with various diseases.

Benefits of University Hospital Cologne
International Awards and Achievements
Main specializations at University Hospital Cologne
Diagnostics at University Hospital Cologne
Online and offline consultations at University Hospital Cologne: order of conduction
Preparing the necessary documents for your trip to University Hospital Cologne
Quarantine restrictions during COVID-19 pandemic

Benefits of University Hospital Cologne

The main advantage of University Hospital Cologne is the introduction of the latest innovations in diagnostics, therapy and surgery.
Thus, the hospital regularly receives grants for research, actively participates in the improvement of known methods of treatment and develops new ones. And cooperation with other world clinics gives doctors the opportunity to constantly grow and develop the methods of both diagnostics and treatment of diseases. Therefore, thousands of patients from Germany and other countries go to University Hospital Cologne for treatment.
  • High-tech equipment
    Stereotaxy is a minimally invasive surgical technique that allows, based on computer calculations, to accurately penetrate deep areas of the brain through minimal openings. In Germany, five clinics practice this technique, and University Hospital Cologne is one of them.
  • More than 200 000 patients a year
    Every year, University Hospital Cologne sees over 200 000 patients. The professionalism and friendliness of the staff, as well as the quality of medical care help this clinic to be highly regarded in Germany and around the world.
  • Doctors, who are included in the list of TOP specialists of the world
    The ranking of the best doctors in Germany, which is regularly updated by Focus magazine, includes doctors from University Hospital Cologne. Also, medical workers annually improve their qualifications and take various courses in many countries of the world: the USA, Great Britain, France, Canada and others.

University Hospital Cologne — International Awards and Achievements

Университетская клиника Кёльна
Университетская клиника Кёльна
Университетская клиника Кёльна
Университетская клиника Кёльна
Университетская клиника Кёльна

Main specializations at University Hospital Cologne

Multidisciplinary University Hospital Cologne was founded in 1908 and includes 59 centers and institutes. The clinic has more than 50 specializations.
Doctors successfully treat various diseases from oncology to rare diseases at all stages.


Doctors of University Hospital Cologne carry out diagnostics, conservative (chemo-, radio- and targeted therapy) and surgical interventions at all stages and various localizations. Oncologists often prescribe a complex treatment against tumors to increase its effectiveness.
Center for Integrated Oncology at University Hospital Cologne
The Center for Integrated Oncology in University Hospital Cologne provides excellent results in the early detection, diagnostics and treatment of all oncological diseases.
Since 2018, the medical director of University Hospital Cologne, together with the University Cancer Centers from Aachen, Bonn and Düsseldorf, has been developing cancer medications for 11 million people at the "Center for Integrated Oncology - Aachen, Bonn, Cologne, Düsseldorf".
In the oncology department of University Hospital Cologne, patients are monitored by an interdisciplinary team of surgeons, radiologists, neuroradiologists, oncologists and psycho-oncologists based on the latest scientific findings.

Within the framework of regular interdisciplinary conferences on tumors, an individual therapy concept is developed for each patient, taking into account their clinical picture. The center is recognized as the Best Cancer Center in the country. The Center for Integrated Oncology at University Hospital Cologne has been certified as a Cancer Center by the German Cancer Society in 2013. It specializes in 25 oncological diseases.
Breast Cancer Center
Breast cancer is the most common form of cancer in women. With the help of complex and more gentle tumor treatments at University Hospital Cologne, cancer is treated more successfully than a few years ago in other countries.

Diagnostic methods at University Hospital Cologne:

Biopsy. It is possible to determine if the tumor is benign or malignant only by examining the tissue.

Breast sonography can display up to four levels of nodes. It is also a proven way to distinguish cysts from tumors..

Mammography is a method of an early detection of breast cancer. X-ray of the breast is carried out in two projections, and doctors detect even very small non-palpable formations. This is the only method by which microcalcifications can be reliably detected. This is important because calcifications in the milk ducts can indicate precancerous stages or even advanced forms of cancer.

MRI is one of the most sensitive methods of examining the breast and is often used to clarify findings if mammography and/or ultrasound are inconclusive.

Lymphoscintigraphy is a method that shows the presence of metastases in the lymph nodes in order to assess the prognosis and prescribe the correct treatment.

Skeletal scintigraphy is the safest method for excluding or detecting skeletal metastases in breast cancer. A small amount of a weakly radioactive phosphate substance is injected intravenously, which is temporarily deposited on the skeleton and thereby reveals bone cancer activity. The method detects metastases in the early stages.

Breast cancer treatment at University Hospital Cologne:

Surgical removal of the tumor. Doctors remove tumor from the breast with a safety margin. They also remove lymph nodes from the armpit. The procedure is influenced by the location and size of the tumor, the size of the breast, the patient's age, and their desire to retain the breast.

Neoadjuvant therapy. In the case of large tumors or tumors with an inflammatory component, hormonal medication is used. The method of neoadjuvant therapy is prescribed in combination with other methods of treatment (surgery, radio- or chemotherapy).

Chemotherapy. If the tumor does not have hormone receptors, or if a combination of factors increases the risk of recurrence, chemotherapy (cytostatic therapy) is prescribed. During chemotherapy, the doctor prescribes medications that act on dividing cells.

Hormonal therapy is prescribed if the tumor has hormone receptors. The number of hormone receptors is determined by the pathologist during histological examination.

Radiation therapy. X-rays are used locally to suppress the growth of cancer cells. After breast-conserving surgery, the remnants of cancer cells must be removed. In advanced tumors, it is used to reduce the size of the tumor or to destroy metastases.

Acute leukemia and myelodysplastic syndromes
Acute leukemia and myelodysplastic syndromes are among the main areas of focus at University Hospital Cologne. The clinic has one of the largest centers in Europe for specialized care for patients with Acute myeloid leukemia, Acute lymphoblastic leukemia and Myelodysplastic syndromes.

The laboratory of molecular hematology and oncology of University Hospital Cologne has the necessary research methods. Doctors use telemicroscopy to discuss critical cases with regional colleagues and, in some cases, send materials to reference laboratories for further study.

Doctors perform chemo- and radiotherapy, successfully transplant stem cells. Maintenance therapy during remission is also used for treatment.
If acute leukemia or myelodysplasia is in the last stages and cannot be cured, then doctors resort to palliative therapy. This may be mild therapy directed against the underlying disease and/or various approaches aimed at preventing complications (prevention of infection or bleeding) or relieving the pain syndrome to improve the patient's life.

Bladder cancer

Bladder cancer is the most common tumor of the urinary tract and ranks 4th in men and 8th in women among solid malignant tumors. About 70% of bladder tumors are detected at an early stage, so only the surface of the bladder is affected during diagnostics. Such tumors are treated with minimally invasive methods.

If the tumor has already grown into the muscles of the bladder, the risk of metastases is significantly increased, so surgical removal of the entire bladder is recommended. As part of this operation, a man's bladder and prostate with the corresponding seminal vesicles are removed.
However, depending on the age of the patient and the extent of the tumor, the bladder may be removed in a manner that spares the prostate and preserves potency and ejaculation.
Depending on the age, past illnesses, the wishes of the patient and the extent of the tumor, a bladder can be replaced from parts of the intestine or urinary incontinence can be diverted using a stoma through the abdominal wall (ileum / skin fistula of the ureter).

Chemotherapy is used for metastatic bladder cancer to kill metastatic tumor cells.

Prostate cancer

Prostate cancer is still the most common malignancy in men, with 64,000 new cases each year. Mortality from prostate cancer is in 3rd place.

University Hospital Cologne is the first in the city and country to offer TRUS-guided fusion biopsy of the prostate (transrectal ultrasound) using MRI.

At University Hospital Cologne, doctors have developed a Lutetium-177 regimen for the successful treatment of prostate cancer, which is currently used throughout the world.

With the help of the scheme, oncologists cure tumors even at the 4th stage, when other methods no longer work.
Another advantage is that the introduction of Lutetium-177 passes without severe side effects or a long recovery period.

Neuro-oncological tumor center
In the neuro-oncological tumor boards, a diagnostic and treatment strategy is created for each patient individually and with the participation of specialists from all related medical fields.

Doctors carry out diagnostics using PET-CT, which is radioactively labeled amino acids (especially with fluoroethyl and L-tyrosine, the so-called FET-PET), anatomical MRI and methods of the so-called Advanced MRI Imaging.

Treatment is carried out using an innovative device - Cyber ​​Knife.
Since 2012, a high-tech radiation device has been available at the Radiotherapy Center at the University Hospital Cologne, which is mainly used to treat hard-to-reach or large tumors.
This precision device allows you to irradiate benign and malignant tumors of the skull, body and spine. It consists of a compact linear accelerator that is mounted on an industrial robot and emits many high-energy beams from different directions to a specific area. Only when all the beams are focused on the target, the tumor tissue is destroyed. The movements of the patient and the tumor are balanced using fluoroscopy and infrared sensors.
Treatment is usually carried out on an outpatient basis and is given as a single dose of radiation or as hypofractionated radiation with 3-5 fractions with an interval of 2-3 days.